Literature DB >> 3024689

Effects of a mu-opioid receptor agonist (codeine phosphate) on visuo-motor coordination and dynamic visual acuity in man.

C M Bradley, A N Nicholson.   

Abstract

Effects of codeine (30, 60 and 90 mg) on visuo-motor coordination and dynamic visual acuity, together with critical flicker fusion, digit symbol substitution, complex reaction time and subjective assessments of mood, were studied from 0.75-2.0 h after ingestion by six healthy female adults. The study was double-blind and placebo controlled, and triprolidine (10 mg) was used as the active control. The effect on visuo-motor coordination was limited and was dose related and linear, and performance was altered on visuo-motor coordination with 60 and 90 mg codeine, and on dynamic visual acuity with 90 mg codeine (P less than 0.05). No other effect of codeine was detected. Modulated neuromuscular function is likely to be the common denominator of the changes in performance with codeine, though nausea, but not sedation, may be a contributory factor. It is possible that altered performance with codeine may involve interactions with different receptors than those which lead to sedation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024689      PMCID: PMC1401180          DOI: 10.1111/j.1365-2125.1986.tb02928.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Problems and solutions to single-dose testing of analgesics: comparison of propoxyphene, codeine, and fenoprofen.

Authors:  S O Waife; C M Gruber; B E Rodda; J F Nash
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-07

2.  Flicker fusion frequency; background and applications.

Authors:  E SIMONSON; J BROZEK
Journal:  Physiol Rev       Date:  1952-07       Impact factor: 37.312

3.  EEG-behavioral dissociation after morphine-and cyclazocine-like drugs in the dog: further evidence for two opiate receptors.

Authors:  W B Pickworth; L G Sharpe
Journal:  Neuropharmacology       Date:  1979-07       Impact factor: 5.250

4.  A recessive lethal super-suppressor mutation in yeast and other psi phenomena.

Authors:  B S Cox
Journal:  Heredity (Edinb)       Date:  1971-04       Impact factor: 3.821

5.  Specific oculomotor deficit after acute methadone. I. Saccadic eye movements.

Authors:  S Rothenberg; S Schottenfeld; K Gross; D Selkoe
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

6.  Participation of medial pontine reticular formation in eye movement generation in monkey.

Authors:  E L Keller
Journal:  J Neurophysiol       Date:  1974-03       Impact factor: 2.714

7.  Oral analgesic studies: pentazocine hydrochloride, codeine, aspirin, and placebo and their influence on response to placebo.

Authors:  T G Kantor; A Sunshine; E Laska; M Meisner; M Hopper
Journal:  Clin Pharmacol Ther       Date:  1966 Jul-Aug       Impact factor: 6.875

8.  Adverse effects of commonly ordered oral narcotics.

Authors:  T G Kantor; M Hopper; E Laska
Journal:  J Clin Pharmacol       Date:  1981-01       Impact factor: 3.126

9.  Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

10.  Specific oculomotor deficit after acute methadone. II. Smooth pursuit eye movements.

Authors:  S Rothenberg; S Schottenfeld; D Selkoe; K Gross
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  7 in total

Review 1.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

2.  Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

3.  Effects of three therapeutic doses of codeine/paracetamol on driving performance, a psychomotor vigilance test, and subjective feelings.

Authors:  Jean-Noël Amato; Sullivan Marie; Véronique Lelong-Boulouard; Magalie Paillet-Loilier; Catherine Berthelon; Antoine Coquerel; Pierre Denise; Marie-Laure Bocca
Journal:  Psychopharmacology (Berl)       Date:  2013-03-09       Impact factor: 4.530

4.  Cognitive and motor function after administration of hydrocodone bitartrate plus ibuprofen, ibuprofen alone, or placebo in healthy subjects with exercise-induced muscle damage: a randomized, repeated-dose, placebo-controlled study.

Authors:  George J Allen; Tamara L Hartl; Shannon Duffany; Stefanie F Smith; Jaci L VanHeest; Jeffrey M Anderson; Jay R Hoffman; William J Kraemer; Carl M Maresh
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

5.  Codeine and clinical impairment in samples in which morphine is not detected.

Authors:  Liliana Bachs; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2003-03-01       Impact factor: 2.953

6.  Studies on performance with aspirin and paracetamol and with the centrally acting analgesics meptazinol and pentazocine.

Authors:  C M Bradley; A N Nicholson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Visual and Auditory Reaction Times of Patients with Opioid Use Disorder.

Authors:  Sema Baykara; Kübra Alban
Journal:  Psychiatry Investig       Date:  2019-08-08       Impact factor: 2.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.